Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Erik Obitz"'
Publikováno v:
Koppelhus, U, Poulsen, J, Grunnet, N, Deleuran, M & Obitz, E 2014, ' Cyclosporine and Extracorporeal Photopheresis are Equipotent in Treating Severe Atopic Dermatitis : A Randomized Cross-Over Study Comparing Two Efficient Treatment Modalities ', Frontiers in medicine, vol. 1, pp. 33 . https://doi.org/10.3389/fmed.2014.00033
Frontiers in Medicine
Frontiers in Medicine, Vol 1 (2014)
Frontiers in Medicine
Frontiers in Medicine, Vol 1 (2014)
BACKGROUND: Severe atopic dermatitis (AD) is a recurrent and debilitating disease often requiring systemic immunosuppressive treatment. The efficacy of cyclosporine A (CsA) is well proven but potential side effects are concerning. Several reports poi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dd3323c202f9660c1170abbd4fcf4cb
https://pure.au.dk/portal/da/publications/cyclosporine-and-extracorporeal-photopheresis-are-equipotent-in-treating-severe-atopic-dermatitis(89d43ac7-bbc6-4c34-abcf-e88b7304be5b).html
https://pure.au.dk/portal/da/publications/cyclosporine-and-extracorporeal-photopheresis-are-equipotent-in-treating-severe-atopic-dermatitis(89d43ac7-bbc6-4c34-abcf-e88b7304be5b).html
Autor:
Annette Østergaard Jensen, Knud Kragballe, B.K. Møller, A. Vangkilde, B. Mark, Erik Obitz, Lars Iversen
Publikováno v:
Jensen, A Ø, Møller, B K, Vangkilde, A, Mark, B, Obitz, E R, Kragballe, K & Iversen, L 2009, ' Treatment of treatment-resistant autoimmune blistering skin disorders with rituximab ', British Journal of Dermatology, vol. 160, no. 6, pp. 1359-61 . https://doi.org/10.1111/j.1365-2133.2009.09132.x
Udgivelsesdato: 2009-Jun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcbfc739846e91d2a48c55e0d12adb27
https://pubmed.ncbi.nlm.nih.gov/19416252
https://pubmed.ncbi.nlm.nih.gov/19416252
Autor:
Roland Kaufmann, Anders Österborg, Madeleine Duvic, Youn H. Kim, Steen Lisby, Susan J. Knox, Robert Gniadecki, Erik Obitz, Timothy M Illidge, Kim M. Knudsen, Ole Baadsgaard, Lars Iversen, Sean Whittaker, Thomas Schwarz, Kevin D. Cooper
Publikováno v:
Kim, Y H, Duvic, M, Obitz, E, Gniadecki, R, Iversen, L, Osterborg, A, Whittaker, S, Illidge, T M, Kaufmann, R, Cooper, K, Knudsen, K M, Lisby, S, Baadsgaard, O & Schwartz, T 2007, ' Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma. ', Blood, vol. 109, no. 11, pp. 4655-62 . https://doi.org/10.1182/blood-2006-12-062877
The efficacy and safety of zanolimumab in patients with refractory cutaneous T-cell lymphoma (CTCL) have been assessed in two phase 2, multicenter, prospective, open-label, uncontrolled clinical studies. Patients with treatment refractory CD4+ CTCL (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28680038a516b69e71ddf68b71d2a136
https://pubmed.ncbi.nlm.nih.gov/17311990
https://pubmed.ncbi.nlm.nih.gov/17311990
Autor:
Nicola Pimpinelli, Lorenzo Cerroni, Gary S. Wood, Earl J. Glusac, Seth R. Stevens, Eric C. Vonderheid, Masahiro Takigawa, Marco Santucci, Maria L. Turner, Robert Knobler, Joan Guitart, Erik Obitz, Elise A. Olsen, Werner Kempf, Brigitte Dréno, Bruce S. Smoller, Sean Whittaker, Stuart R. Lessin, Christian A. Sander, Andreas C. Haeffner, Gladys H. Telang, Keiji Iwatsuki, Peter Heald, Guenter Burg
Publikováno v:
Journal of the American Academy of Dermatology. 53(6)
This editorial review summarizes the results of 5 meetings sponsored by the International Society for Cutaneous Lymphoma at which the clinicopathologic and ancillary features of early mycosis fungoides were critically examined. Based on this analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40635f4455c31f9d3d9e4b2e96883113
https://pubmed.ncbi.nlm.nih.gov/16310068
https://pubmed.ncbi.nlm.nih.gov/16310068
Autor:
Lone Skov, Pia Jensen, Knud Kragballe, Torkil Menné, Hans Henning W. Ibsen, Ole Baadsgaard, Claus Zachariae, Lone Knudsen, Erik Obitz, Henrik Sølvsten, Gregor B.E. Jemec, Elisabeth A. Holm, Jan H. Petersen
Publikováno v:
Archives of Dermatology. 139
Background Psoriasis is characterized by infiltration with mononuclear cells. Especially activated memory CD4 + T cells are critical in the pathogenesis. Interaction between the CD4 receptor and the major histocompatibility complex class II molecule
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b7e977e74f168e577747cead5380af9
https://doi.org/10.1001/archderm.139.11.1433
https://doi.org/10.1001/archderm.139.11.1433